Faster method for detecting disease-causing mutations developed by Pitt researchers

University of Pittsburgh researcher Alexander Star and colleagues at a California-based company, Nanomix, Inc., have developed devices made of carbon nanotubes that can find mutations in genes causing hereditary diseases, they report in the Jan. 16 issue of the journal Proceedings of the National Academy of Science.

This method is less expensive and takes less time than conventional techniques.

Carbon nanotubes are rolled-up sheets of graphite only a few nanometers wide - about the width of a molecule of DNA. The researchers used these nanotubes’ electrical properties to find a particular mutation in the gene that causes hereditary hemochromatosis, a disease in which too much iron accumulates in body tissues.

“The size compatibility between the detector and the detected species - DNA molecules in this case - makes this approach very attractive for further development of label-free electronic methods,” said Star, who is an assistant professor of chemistry at Pitt.

Star and his colleagues at Nanomix also tested fluorescently labeled DNA molecules in order to confirm that DNA had attached to the nanotube surfaces and was subsequently hybridized, or matched to its complementary DNA.

“We have found that electrical measurement of carbon nanotube devices produce sensor results that are comparable to state-of-the-art optical techniques,” Star said.

He added, “The applications of our method for detection of other, more serious genetic diseases can be seen.” Label-free electronic detection of DNA has several advantages over state-of-the-art optical techniques, including cost, time, and simplicity.

“Our technology can bring to market hand-held, field-ready devices for genetic screening, as opposed to laboratory methods using labor-intense labeling and sophisticated optical equipment,” Star said.

This research was partially supported by the National Science Foundation’s Small Business Innovation Research program.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals variability in polygenic risk scores for predicting heart disease